Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | THPO | P40225 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.41 |
| ▸ | MANBA | O00462 | 1/20 | 0.39 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.38 |
| ▸ | GBA1 | P04062 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | HK1 | P19367 | 1/20 | 0.36 |
| ▸ | HK2 | P52789 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14843742 | 1.00 | CYP1A2 (0.41) | CYP1A2NFKB1THPOALDH1A1PMP22 | |
| SCHEMBL14843740 | 1.00 | CYP1A2 (0.41) | CYP1A2NFKB1THPOALDH1A1PMP22 | |
| SCHEMBL28704897 | 0.81 | CYP1A2 (0.39) | CYP1A2NFKB1THPOALDH1A1PMP22 | |
| SCHEMBL27821172 | 0.81 | MANBA (0.39) | CYP1A2NFKB1THPOALDH1A1PMP22 | |
| SCHEMBL14844148 | 0.80 | TYR (0.38) | — | |
| SCHEMBL14844151 | 0.80 | TYR (0.38) | — | |
| SCHEMBL16010800 | 0.80 | TYR (0.38) | — | |
| SCHEMBL9806236 | 0.79 | CYP1A2 (0.45) | CYP1A2NFKB1THPOALDH1A1PMP22 | |
| SCHEMBL16275084 | 0.79 | CYP1A2 (0.45) | CYP1A2NFKB1THPOALDH1A1PMP22 | |
| SCHEMBL3661393 | 0.79 | SLC5A2 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140256924-A1 | CARBOHYDRATE FUNCTIONALISED SURFACES | THE PROVOST, FELLOWS, FOUNDATION SCHOLARS AND THE OTHER MEMBERS OF BOARD OF (IE) | 2014-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140256924-A1 | CARBOHYDRATE FUNCTIONALISED SURFACES | CD2, CD47, CD22 | CYP1A2 3643/4885NFKB1 2101/4885THPO 290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.